Annual Report

The report highlights Pharming's 2015 RUCONEST revenue performance and continued development of therapies for rare diseases. It describes CSR priorities spanning patient safety, employee wellbeing, animal welfare and environmental responsibility. At year-end, the company employed 79 people, while the report also provides consolidated financial statements and detailed governance disclosures.